 |
Previous Article
The Journal of Neuroscience, May 1, 2001, 21(9):3295-3302
Excitatory Nicotinic and Desensitizing Muscarinic (M2) Effects on
C-Nociceptors in Isolated Rat Skin
Nadia
Bernardini1,
Susanne K.
Sauer1,
Rainer
Haberberger2,
Michael J. M.
Fischer1, and
Peter W.
Reeh1
1 Institut für Physiologie und Experimentelle
Pathophysiologie, Erlangen-Universität, Universitätstraße
17, 91054 Erlangen, Germany, and 2 Institut für
Anatomie und Zellbiologie, Justus-Liebig-Universität, Aulweg 123, 353885 Giessen, Germany
 |
ABSTRACT |
The actions of different cholinergic agonists and antagonists were
investigated on nociceptive afferents using the rat skin-saphenous nerve preparation, in vitro. Nicotine was able to weakly
excite C-nociceptors and to induce a mild sensitization to heat
stimulation (in 77% of tested fibers) in a dose-dependent manner
(10 6 to
10 5 M),
but it caused no alteration in mechanical responsiveness tested
with von Frey hairs. Muscarine did not induce a significant nociceptor
excitation, but almost all fibers exhibited a marked desensitization to
mechanical and heat stimuli in a dose-dependent manner (from
10 6 to
10 4 M). The
muscarinic effects could be prevented by the general muscarinic
antagonist scopolamine (10 5
M), by the M3 antagonist
1,1-dimethyl-4-diphenylacetoxypiperidium oxide
(10 6 M) co-applied
with the M2 antagonist gallamine
(10 5 M), and by
gallamine alone. As positive control we used the relatively M2-selective agonist arecaidine
(10 6 to
10 5 M),
obtaining a similar desensitizing effect as with muscarine. Finally, we
performed an immunocytochemical study that demonstrated the presence of
M2 but not M3 receptors in thin epidermal nerve fibers of the rat hairy
skin. Altogether, these data demonstrate opposite effects of nicotinic
and muscarinic receptor stimulation on cutaneous nociceptors. M2
receptor-mediated depression of nociceptive responsiveness may convey a
therapeutic, i.e., analgesic or antinociceptive, potential.
Key words:
acetylcholine; analgesia; cholinergic; mechanosensitivity; pain; sensitization
 |
INTRODUCTION |
Acetylcholine (ACh) is the
classical neurotransmitter activating nicotinic as well as muscarinic
receptor subtypes. ACh is generally considered to be an algogenic agent
because it has been shown to produce burning pain when applied to human
skin (Keele and Armstrong, 1964 ; Rukwied and Heyer, 1999 ). Nonetheless,
its role in physiological pain mechanisms has not been clearly
understood. In fact, it is still unknown whether ACh appears in
inflammatory exudates or under other painful conditions, but possible
extraneuronal sources of ACh in the close vicinity of primary afferent
terminals have meanwhile been identified. For example, in the corneal
epithelial cells, high concentrations of ACh have been found that may
be released after injury, and ACh has been shown to excite corneal nerve endings (Pesin and Candia, 1982 ; Tanellian, 1991 ). Regarding skin, it has been demonstrated that human keratinocytes are able to
synthesize and secrete ACh. Here, ACh plays a role in regulating cell-cell attachment, but in addition, it may be released in larger amounts after cutaneous injury (Grando et al., 1993 ). Moreover, the
ability of dorsal root ganglion (DRG) cells to synthesize ACh has been
reported (Tata et al., 1994 ).
In the rat skin-nerve preparation and in the cornea, only unmyelinated
C-fiber endings were excited by ACh and its analog carbachol,
respectively (Tanellian, 1991 ; Steen and Reeh, 1993 ). The major finding
was that repeated carbachol treatment of polymodal nociceptors left almost all fibers with a marked and sustained desensitization to mechanical stimulation (Steen and Reeh, 1993 ). If
the physiological role of ACh lay in a capacity to desensitize nociceptors, this may convey a therapeutic, i.e., analgesic or antinociceptive, potential. A selective desensitizing effect of ACh
would not be expected to be mediated by the nicotinic receptor-ion channel complex but by one of the five muscarinic receptor subtypes that connect to different second messenger pathways (Mei et al., 1989 ).
The presence of muscarinic AChRs (mAChRs) (Bauer et al., 1994 ; Wanke et
al., 1994 ; Bernardini et al., 1998 ; Haberberger et al., 1999 ; Tata et
al., 1999 ) as well as nicotinic AChRs (nAChRs) (Boyd et al., 1991 ; Zoli
et al., 1995 ; Flores at al. 1996 ; Liu et al., 1998 ) in DRG cells is
established. On the other hand, it is well documented that both
nicotinic (Rao et al., 1996 ; Bannon et al., 1998 ; Traynor, 1998 ) and
muscarinic receptors (Bartolini et al., 1992 ; Naguib and Yaksh, 1997 ;
Ellis et al., 1999 ; Gomeza et al., 1999 ) are involved in the modulation
of central nociception. Intrathecal administration of nicotinic
agonists was shown to block heat nociception in the tail-flick
assay (Rao et al., 1996 ; Bannon et al., 1998 ), and recent knock-out
studies showed a crucial role of the muscarinic M2 and M4 receptor
subtypes in mediating analgesic effects of oxotremorine administration
as assessed in the hot-plate and the tail-flick tests (Ellis et al.,
1999 ; Gomeza et al., 1999 ).
The present electrophysiological study sought to differentiate the
effects of muscarinic and nicotinic agonists and antagonists on
peripheral nociceptive terminals to clarify the physiological role of
ACh in nociception.
 |
MATERIALS AND METHODS |
This study was performed using the in vitro rat
skin-saphenous nerve preparation that has been described previously in
detail (Reeh, 1986 , 1988 ).
General procedures
The preparations were obtained from 62 home-bred male Wistar
rats (200-380 gm) that were killed in a pure CO2
atmosphere. The saphenous nerve in continuity with the dorsal hindpaw
skin was subcutaneously dissected and excised. The skin was pinned out,
corium side up, in a Perspex chamber and kept under laminar superfusion (16 ml/min). The saphenous nerve was pulled through a hole
into a second chamber where the aqueous solution [synthetic interstitial fluid (SIF); see below] was overlaid with paraffin oil;
here the nerve was teased into smaller and smaller filaments until
single-fiber unitary activity could be recorded via gold wire electrodes.
The skin was superfused with SIF containing (in mM):
108 NaCl, 3.48 KCl, 3.5 MgSO4, 26 NaHCO3, 1.7 NaH2PO4, 1.5 CaCl2, 9.6 sodium gluconate, 5.55 glucose, and
7.6 sucrose (Bretag, 1969 ), thermostatically controlled at 32°C, and
bubbled continuously with carbogen (95% O2, 5%
CO2).
Characterization of C-fibers
Receptive fields of C-fibers were located by probing the corium
side of the skin with a blunt glass rod. The nerve endings were
electrically stimulated in their receptive fields via Teflon-insulated steel microelectrodes (impedance: 6-10 M ) to measure conduction velocity and establish the identity of mechanically and electrically evoked impulses using the "collision technique" (Iggo, 1958 ). The
thresholds to mechanical stimulation were tested with a set of 18 von
Frey hairs calibrated from 1 to 256 mN in a geometric series
(xi = xi-1 × 2). Heat responsiveness was
examined by focusing a halogen lamp through the translucent bottom of
the skin chamber onto the epidermal side of the isolated receptive
field. At the opposite corium side, the linearly increasing temperature
(from 32 to 46°C in 20 sec, which corresponds to a rise from 32 to
52°C at the epidermal surface) (Reeh, 1986 ) was feedback controlled by a thermocouple. To isolate the receptive field, a metal ring was
placed over the respective corium area, and the SIF content was
evacuated. The temperature corresponding to the second spike of the
heat response of a fiber was considered to be "heat threshold." For
testing cold responsiveness, the ring was filled with cooled SIF at
~4°C.
Chemical stimulation
The metal rings to isolate receptive fields were also used
for chemical stimulations. They had inner diameters of 6.6-9.6 mm and
comprised volumes of 0.3-0.6 ml that were perfused at 32°C with 2.25 ml/min to produce a turbulent flow. All solutions were bubbled
continuously with carbogen.
Stock solutions
(10 3
M) of all drugs used were kept frozen ( 20°C) and were
freshly diluted in SIF for every experiment. The following agents were
used: arecaidine-but-2ynyl ester (Tocris), gallamine-triethiodide
(Sigma, St. Louis, MO), muscarine chloride (Sigma), nicotine (Sigma),
scopolamine hydrobromide (Sigma) and 1,1 dimethyl-4-diphenylacetoxypiperidium iodide (4-DAMP) (Sigma).
Control experiments. SIF was applied at the receptor field
for 5 min before and after the mechanical and heat responsiveness were tested.
Agonist experiments. The cholinergic agonists nicotine,
muscarine, or arecaidine at increasing
10 6,
10 5, and
10 4 (only
muscarine) M concentrations were superfused over
the receptive fields for 5 min at 10 min intervals. After each drug
administration the mechanical and heat thresholds were tested (Fig.
1A,B).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 1.
Original recording from two C-MH fibers of the
saphenous nerve with receptive fields in isolated rat hairy skin,
illustrating also the typical experimental protocol. Instantaneous
discharge rates are plotted over a time scale of two different
resolutions showing heat responses (32-46°C in 20 sec; gray
columns) and responses to chemical stimuli (of 5 min duration);
von Frey thresholds are indicated by open triangles.
A shows nicotine responses and a dose-dependently
induced sensitization to heat. B shows lack of
muscarine-induced excitation and dose-dependent desensitization to heat
and mechanical (von Frey) stimulation.
|
|
Antagonist experiments. The general muscarinic antagonist
scopolamine and the specific M2 antagonist gallamine were used at 10 5
M concentration, superfused over the receptive
fields for 5 min, and in combination with muscarine
10 5
M for an additional 5 min. Mechanical and heat
thresholds were tested before and after drug application.
Data analysis
The single nerve fiber activity was recorded with a low-noise
AC-coupled amplifier and monitored on a loudspeaker and an
oscilloscope. The recordings were digitized and processed in an AT-type
computer using a DAP 1200 interface card (Microstar, Redmond, WA). The data were analyzed off-line using the Spike/Spidi software package that
provides a template-matching procedure for automatic spike discrimination (Forster and Handwerker, 1990 ).
The magnitude of a chemical response was assessed as the total number
of spikes counted in the 5 min of stimulation. Statistical comparisons
were made using the t test for dependent and independent variables. Nonparametric statistical analyses of von Frey threshold changes were made using the Wilcoxon matched pair test. Differences were considered statistically significant at p < 0.05. The statistical evaluations of changes in heat and mechanical (von
Frey) thresholds were complicated by the fact that many fibers were so
strongly desensitized after muscarinic agonist administration that heat stimulation (up to 46°C) no longer excited them, and unquantifiable probing with a glass rod was needed to stimulate them mechanically. This resulted in "missing values" that led to underestimation of
the effect in the statistical analysis. For illustration, those values
are indicated by arrowheads in Figures 3 and 5. In the case
of heat responsiveness lost, 46°C was entered as default value for
heat threshold to enable statistical comparison.
Immunohistochemistry
Specimens for immunohistochemistry were obtained from five adult
rats (Wistar, Harlan Winkelmann, Borchem, Germany) of either sex that
were killed by inhalation of chloroform followed by transcardial perfusion with rinsing solution containing polyvinylpyrrolidone and
procainamide-HCl (Forssmann et al., 1977 ) and then with Zamboni's fixative (Zamboni and de Martino, 1967 ). Specimens of hairy skin from
the hindpaws were dissected, washed in 0.1 M phosphate
buffer (PB), cryoprotected in 18% sucrose in 0.1 M PB, and
frozen in liquid nitrogen. Sections at a thickness of 10 µm were made
using a cryostat (Jung Frigocut 1900 E, Leica, Bensheim, Germany).
After blocking with PBS containing 10% normal porcine serum, 0.1%
bovine serum albumin, and 0.5% Tween 20, sections were covered
overnight with mixtures of primary antisera. Polyclonal M2- or
M3-antisera (Biotrend, Köln, Germany) diluted in PBS/NaCl 1:1000
were combined with the monoclonal protein gene product (PGP) 9.5 antibody 1:400 (Biotrend). Then, sections were washed in 0.1 M PB and covered for 1 hr with a mixture of Cy-3-conjugated
anti-rabbit IgG (1:3000; Dianova, Hamburg, Germany) and FITC-conjugated
anti-mouse IgG (1:400; Cappel, West Chester, PA), washed out, and
coverslipped in carbonate-buffered glycerol, pH 8.6. The slides were
evaluated independently by two observers by epifluorescence microscopy
(Olympus BX 60 F, Hamburg, Germany) using appropriate filter
combinations for Cy3 (excitation filter 525-560 nm, barrier filter
570-650 nm) and FITC (excitation filter 460-490 nm, barrier filter
515-550 nm). Controls were run by omitting the first antibody.
 |
RESULTS |
We examined 88 mechanosensitive C-fibers from the rat hairy skin,
in vitro; 73% were sensitive to mechanical and heat
stimulation (C-MH), 12% were sensitive to mechanical and cold
stimulation (C-MC), and 15% were high-threshold mechanosensitive
(C-HTM) and did not respond to thermal stimulations.
Controls
For negative control experiments, 13 C-MH fibers (cv = 0.44 ± 0.10 m/sec) were used. We found nearly no
spontaneous activity during 5 min of superfusion with SIF (Fig.
2) and no changes of the sensory properties;
in fact, mechanical and heat thresholds remained constant after SIF
administration (Figs. 3A,
5A).

View larger version (15K):
[in this window]
[in a new window]
|
Figure 2.
Concentration-response curves for induced C-fiber
excitation. Nicotine-induced discharge was of a significantly higher
rate than spontaneous activity (spa; recorded
during 5 min before chemical stimulation), and
10 5 M nicotine was
significantly more effective than
10 6 M
(*p < 0.05, t test). Both
concentrations of nicotine induced significantly more discharge than
muscarine (*p < 0.05, t
test).
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Figure 3.
Heat thresholds of C-MH fibers before and after
administration of cholinergic agonists and antagonists.
Arrowheads in C and D
indicate fibers no longer excited up to 46°C.
|
|
Although the population of C-fibers examined was rather heterogeneous,
the differences between the median von Frey and the mean heat responses
were not significant between the distinct groups of fibers tested with
the various drugs.
Nicotine
A population of 19 fibers [conduction velocity (cv) = 0.57 ± 0.22 m/sec] consisting of nine C-MHs, six C-MCs, and four
C-HTMs was tested with nicotine at increasing
10 6 to
10 5
M concentrations (Fig. 1A). Regardless of
the fiber type, nicotine induced a significant
(p < 0.05 compared with control period) and
dose-dependent excitation with very low discharge rate; 12 of the 19 fibers responded. Seven of the nine C-MH fibers were significantly
(p < 0.05) and dose-dependently sensitized
against heat stimulation, showing a decrease of the heat threshold
(Fig. 3B) and an increase of the heat-induced discharge
(from 12 ± 7 to 18 ± 9 and 23 ± 16 spikes after
10 6 and
10 5
M nicotine, respectively) (Fig.
4A). In the majority of the
fibers the heat threshold dropped by >3°C (Table
1). On the contrary, there was no
alteration of the median von Frey threshold (Fig. 5B, Table
2).

View larger version (19K):
[in this window]
[in a new window]
|
Figure 4.
Averaged per stimulus-time histograms of heat
responses of C-MH units. Nicotine (A) induced a
dose-dependent sensitization, lowering the threshold and increasing the
mean response. Muscarine (B) and the M2-agonist
arecaidine (C) induced a dose-dependent
desensitization with increased threshold and reduced response.
D illustrates the heat stimulus. In A, a
few white columns are masked by gray
ones, and in C three black columns vanish
behind gray ones, but in all cases the differences were
negligible (see Results for statistics).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Figure 5.
Mechanical thresholds tested with von Frey
hairs before and after administration of cholinergic agonists and
antagonists. Arrowheads in C and
D indicate fibers responding only to a glass rod
pressure (~1000 mN).
|
|
Muscarine
Twenty C-fibers (cv = 0.59 ± 0.20 m/sec) 11 C-MH, 3 C-MC, 6 C-HTM were tested with muscarine at increasing
10 6,
10 5, and
10 4 M
concentrations (Fig. 1B); 7 of 20 units showed a
slight, apparently dose-dependent but not significant excitation (Fig.
2). Ten of 11 C-MH units revealed a marked and dose-dependent
desensitization against heat stimulation (Figs. 3C,
4B, Table 1). Most of the C-MH fibers showed an
increase of the heat threshold by >3°C (Fig. 3C, Table 1)
or were no longer excited by heat stimulation up to 46°C (Fig.
3C, arrows, Table 1). The increase of the heat thresholds was always accompanied by a decrease in the numbers of
spikes during heat stimulation (on average from 16 ± 9 to
10.2 ± 8, 6.2 ± 5, and 2 ± 1.5 spikes after
increasing muscarine concentrations) as reflected in the averaged heat
responses (Fig. 4B). Independent of fiber type, 19 of
20 C-fibers tested were significantly and dose-dependently desensitized
to mechanical stimulation (Fig. 5C). In particular, 6 of
these 19 fibers responded only to probing of the receptive field with a
blunt glass rod applying ~1000 mN of force (Fig. 5C,
arrows, Table 2); among them, four C-MH fibers also no
longer responded to heat stimulation.
Muscarinic antagonists
Seven fibers (one C-MC, one C-HTM, five C-MH; cv = 0.39 ± 0.08 m/sec) were tested with the general muscarinic
antagonist scopolamine (10 5
M) alone and in combination with muscarine at the same
concentration. Neither after antagonist alone nor after co-application
with muscarine did we find relevant changes of the von Frey or of the
heat thresholds (Figs. 3E, 5E). These results
were comparable with those of the negative control experiments.
To approach the question of the muscarinic receptor subtype
involved in the desensitization, we performed the same type of antagonist experiments using a combination of the noncompetitive M2
antagonist gallamine with the competitive M3 antagonist 4-DAMP (one
C-MC, six C-MH; cv = 0.45 ± 0.09 m/sec), obtaining results comparable to those with scopolamine (no change of sensory properties after gallamine alone or in co-application with muscarine; data not
shown). Seven (two C-HTM, five C-MH; cv = 0.49 ± 0.2 m/sec) and 14 (C-MH; cv = 0.55 ± 0.16 m/sec) other fibers were
tested with either gallamine
(10 5
M) or 4-DAMP
(10 6
M), respectively. As shown in Figures 3F and
5F, gallamine was able to prevent muscarine-induced
desensitization, because there were no changes of the von Frey and heat
thresholds after drug superfusion. However, also on co-application of
4-DAMP with muscarine, only a slight desensitization to heat and no
changes of the von Frey thresholds occurred (data not shown); this
could be attributable to the fact that the subtype selectivity of
4-DAMP (Caulfield, 1993 ) is not confined to the M3 receptor
(Kd = 8.9-9.3) but overlaps with
antagonistic effects on M1 (Kd = 8.6-9.2), M2 (Kd = 7.8-8.4), M4
(Kd = 8.4-9.4), and M5
(Kd = 8.9-9.0).
Arecaidine
To further support M2 involvement in nociceptor desensitization,
the M2 agonist arecaidine was tested at
10 6 and
10 5
M concentrations on eight C-MH (cv = 0.43 ± 0.20) fibers. Seven of eight fibers showed a clear dose-dependent
desensitization to heat stimulation: in three of them the heat
threshold was increased by >2°C and in another two by >3°C, and
two units no longer responded to heat stimulation up to 46°C (Fig.
3D, Table 1). Increases in heat threshold were always
accompanied by dose-dependent decreases in heat-induced discharge (on
average from 22 ± 15 to 13 ± 11 and 5.6 ± 4 spikes
after 10 6
and 10 5
M arecaidine, respectively) (Fig.
4D). In all fibers we also found a marked
dose-dependent desensitization to mechanical stimulation (Fig.
5D): in three of eight the mechanical threshold was more than doubled, in four of eight it increased >2.8-fold, and one fiber
responded only to probing of the receptive field with the glass rod
(~1000 mN); the same unit no longer responded to heat stimulation but
was still electrically excitable (Fig. 5D, Table 2).
Immunohistochemistry
M2, but not M3, receptor immunoreactivity (IR) was present in PGP
9.5-positive nerve fibers at the epidermis-dermis border (Fig.
6a,c). Keratinocytes in
the basal layer of the epidermis showed a pericellular M3-IR (Fig.
6c). M2-IR could be detected in the upper epidermal cell
layers, whereas the deeper layers showed only a light staining (Fig.
6a).

View larger version (63K):
[in this window]
[in a new window]
|
Figure 6.
Immunocytochemical detection of M2 but not M3 ACh
receptors in rat cutaneous nerve fibers. Immunoreactivity for M2R, M3R,
and PGP 9.5 at the epidermis-dermis border of the rat skin. Some nerve
fibers showed immunoreactivity for M2R and PGP 9.5 (arrowheads in a, b),
whereas M3R immunoreactivity could not be observed in PGP 9.5 nerve
fibers at the epidermis-dermis border (arrows in
c, d). Note the strong M2R-IR of the
upper epidermal and the strong M3R-immunoreactivity of the basal
epidermal layer. Scale bar, 40 µm.
|
|
 |
DISCUSSION |
In the present study we have analyzed the different effects of
muscarinic and nicotinic agonists and antagonists on cutaneous nociceptors in the isolated rat skin. Nicotine was able to excite C-nociceptors and to induce a sensitization against heat stimulation in
a dose-dependent manner but no alteration in the mechanical responsiveness. Heat sensitization was found in 77% of the C-MH fibers
tested; in 71% of these, the heat threshold dropped by >3°C. On the
other hand, muscarine did not produce a significant excitation, but
almost all fibers revealed a marked desensitization to mechanical (99%
of the C-fibers tested) and heat (90% of the C-MH tested) stimulation
in a dose-dependent way. Actually 36 and 54% of the C-MH fibers were
completely desensitized to mechanical and heat stimulation,
respectively. Also ~33% of the C-HTM showed a complete muscarinic
desensitization against mechanical stimuli. The muscarinic effects
could be completely prevented by the general muscarinic antagonist
scopolamine, by the co-application of the M3 antagonist 4-DAMP together
with the M2 antagonist gallamine, and by gallamine alone. These results
indicated an M2 or M3 receptor involvement in the desensitization
induced by muscarine. For further elucidation we used arecaidine, an
M2-specific agonist; here we found the same effects as with muscarine
alone. Actually 87 and 100% of the fibers were desensitized after
arecaidine against heat and mechanical stimulation, respectively.
Moreover, our immunohistochemical study showed the presence of M2, but
not M3, receptors in the unmyelinated nerve fibers at the
epidermis-dermis border.
Although acetylcholine has not been recognized as a neurotransmitter in
any one of the DRG neuronal populations, it has been demonstrated that
sensory neurons are able to synthesize ACh as well as choline
acetyltranferase and acetylcholinesterase (Tata et al., 1994 ).
Moreover, recent experiments demonstrate a widespread expression of the
cholinergic system in non-neuronal cells. The synthesizing enzyme
choline acetyltranferase, the signaling molecule ACh, and the
respective receptors (nicotinic and muscarinic) are expressed in
epithelial cells, e.g., in human airways, alimentary tract, and
epidermis (Wessler et al., 1998 , 1999 ). Human keratinocytes as well as
fibroblasts and glial cells are able to synthesize ACh (Grando et al.,
1993 ; Wessler et al., 1997 ; Buchli et al., 1999 ).
Neuronal nicotinic receptors belong to the superfamily of
ligand-gated ion channels. They exhibit high conductance for
Ca2+, which may allow them to take part in
synaptic mechanisms in which Ca2+ acts as
second messenger to control other ion channels and other intracellular
functions (Lindstrom et al., 1996 ). The presence of nicotinic receptors
in sensory neurons is well documented (Boyd et al., 1991 ), and recent
in situ hybridization studies have demonstrated that these
receptors belong to the 3 4 subtype (Zoli et al., 1995 ; Flores et
al., 1996 ). Our study confirms the presence of functional nAChRs in
sensory neurons and demonstrates that they are implicated in C-fiber
excitation and heat sensitization. Nicotine-induced excitatory
responses in rat sensory neurons (Sucher et al., 1990 ; Roberts et al.,
1995 ), in rabbit corneal afferent nerves (Tanellian, 1991 ), and in rat
trigeminal ganglion neurons (Liu et al., 1998 ) have also been demonstrated.
The activation of nicotine receptors in dorsal root ganglion (Zhong and
Nurse, 1997 ) and in PC12 (Harkins and Fox, 1998 ) cells provides an
important Ca2+ entry pathway through both
Ca2+-permeable nAChR and voltage-dependent
Ca2+ channels. In addition, in
C-nociceptors and DRG cells, experimental elevation of intracellular
calcium levels induces an increase in the heat responses (Kress and
Guenther, 1999 ). Altogether this evidence can easily explain the
sensitization against heat stimulation that we found after nicotine administration.
Five genes that encode mAChR proteins (m1-m5) have been identified
(Bonner, 1989 ; Bonner et al., 1988 ). They belong to the superfamily of
G-protein-coupled receptors and activate different second messenger
transduction systems, with m1, m3, and m5 (via the subunits of the
Gq/11 family) acting through the phosphoinositol cascade, whereas m2 and m4 (via Gi and
G0 subunits) mainly lower cAMP levels
(Caulfield and Birdsall, 1998 ). Many studies reported the presence of
muscarinic receptors in avian (Bernardini et al., 1998 ; Tata et al.,
2000 ) and mammalian (Steen and Reeh, 1993 ; Bauer et al., 1994 ; Wanke et
al., 1994 ; Bernardini et al., 1999 ) afferent neurons.
The main finding of the present study was that muscarine treatment of
C-units left them with a marked and sustained desensitization to
mechanical and heat stimuli. The mechanical desensitization is in
agreement with preceding data gained from the same preparation (Steen
and Reeh, 1993 ); it was reported that the ACh analog carbachol excited
C-nociceptors and at the same time produced a long-lasting (up
to 45 min) desensitization to mechanical stimulation. Most of the
literature regarding the action of different mediators on nociceptors
deals with questions of sensitization (e.g., by inflammatory
mediators). So, the literature is poor in respect to endogenous
desensitizing effects, but a recent study showed that
GABAB receptors, which act through G-proteins to
regulate potassium and calcium channels, also inhibit
mechanosensitivity of primary afferent endings (Page and Blackshaw,
1999 ). M2 receptors inducing desensitization can be explained by the
fact that apart from lowering the intracellular cAMP concentration,
they also gate a low-threshold voltage-operated
K+ channel that builds up a
hyperpolarizing force (Pan and Williams, 1994 ). The activation
of these K+ channel can also explain the
lack of excitation that we found after muscarinic agonist
administration. In the skin-nerve preparation application of cAMP,
analogs increased the sensitivity for both heat and mechanical
stimulation (Kress et al., 1996 ). So, the opposite, lowering
intracellular cAMP (through Gi and/or
G0), could contribute to explain the
desensitization of nociceptors.
Our results clearly show that the M2 muscarinic subtype is implicated
in nociceptor desensitization, and the expression of this subtype in
sensory neurons is well documented (Bernardini et al., 1999 ;
Haberberger et al., 1999 ; Tata et al., 1999 ). In addition we are
showing the presence of M2-IR in nerve fibers in the epidermis of rat
hairy skin; this confirms previous immunohistochemical studies
in the same preparation (Haberberger and Bodenbenner, 2000 ).
On the other hand, the involvement of both nicotinic and muscarinic
receptors in the modulation of central nociception is well documented.
Intrathecal administration of nicotinic agonists has been shown to
block heat nociception in the tail-flick assay (Rao et al., 1996 ;
Bannon et al., 1998 ); among them, epibatidine, is the most powerful.
Moreover, the antinociceptive effect of epibatidine was not blocked by
the opioid antagonist naloxone, suggesting a therapeutic action
different from that of morphine and a potentially novel therapeutic
mechanism of providing pain relief (Traynor, 1998 ). Muscarinic
receptors also seem to be implied in central antinociceptive mechanisms
(Bartolini et al., 1992 ; Naguib and Yaksh, 1997 ). The latest research,
using knock-out mice, found a crucial role of M2 and M4 receptor
subtypes in mediating analgesic effects as assessed in the hot-plate
and tail-flick tests after oxotremorine administration, which does not
exclude the involvement of peripheral nociceptors (Ellis et al., 1999 ; Gomeza et al., 1999 ).
In conclusion, the desensitizing muscarine effect was stronger and more
general, blunting mechanical and heat sensitivity, than the sensitizing
and excitatory nicotinic action. These findings are in full agreement
with the previously reported mixed effect of carbachol, weakly exciting
and desensitizing nociceptors to mechanical stimulation (Steen and
Reeh, 1993 ). Overall desensitization by endogenous ACh may be the
reason why postsurgical patients with joint pain gain benefit from
intra-articular instillation of cholinesterase blockers increasing
local ACh levels (Yang et al., 1998 ). In the skin, keratinocytes are a
likely source of continuous ACh release (Grando et al., 1993 ), in the
closest possible vicinity to epidermal nerve endings equipped with M2
receptors. Thus, one might speculate that nociceptive
mechanosensitivity is normally under permanent inhibitory control that
may wane when the keratinocytes are damaged, resulting in disinhibition
and mechanical hyperalgesia.
 |
FOOTNOTES |
Received Dec. 27, 2000; revised Feb. 20, 2001; accepted Feb. 26, 2001.
This work was supported by Deutsche Forschungsgemeinschaft, SFB
353-B12. N. Bernardini was supported by a post-graduate fellowship of
the Universitá "La Sapienza," Roma, Italy. We thank I. Muller-Roth and U. Nesnidal for technical assistance. Dr. Gabor Pethoe
provided technical advice.
Correspondence should be addressed to Nadia Bernardini, Institut
für Physiologie und Experimentelle Pathophysiologie,
Erlangen-Universität, Universitätstrasse 17, 91054 Erlangen, Germany. E-mail:
bernardini{at}physiologie1.uni-erlangen.de.
 |
REFERENCES |
-
Bannon AW,
Decker MW,
Holladay MW,
Curzon P,
Donnelly-Roberts D,
Puttfarcken PS,
Bitner RS,
Diaz A,
Dickenson AH,
Porsolt RD,
Williams M,
Arneric SP
(1998)
Broad-sprectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
Science
279:77-81[Abstract/Free Full Text].
-
Bartolini A,
Ghelardini C,
Fantetti L,
Malcangio M,
Malmberg-Aiello P,
Giotti A
(1992)
Role of muscarinic receptor subtypes in central antinociception.
Br J Pharmacol
105:77-82[Web of Science][Medline].
-
Bauer MB,
Murphy S,
Gebhart GF
(1994)
Muscarinic cholinergic stimulation of the nitric oxide-cyclic GMP signaling system in cultured rat sensory neurons.
Neuroscience
62:351-359[Web of Science][Medline].
-
Bernardini N,
De Stefano ME,
Tata AM,
Biagioni S,
Augusti-Tocco G
(1998)
Neuronal and non-neuronal cell populations of the avian dorsal root ganglia express muscarinic acetylcholine receptors.
Int J Dev Neurosci
16:365-377[Web of Science][Medline].
-
Bernardini N,
Levey AI,
Augusti-Tocco G
(1999)
Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins.
J Peripher Nerv Syst
4:222-232[Web of Science][Medline].
-
Bonner T
(1989)
The molecular basis of muscarinic acetylcholine receptor diversity.
Trends Neurosci
12:148-151[Web of Science][Medline].
-
Bonner T,
Young A,
Brann M
(1988)
Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes.
Neuron
1:403-410[Web of Science][Medline].
-
Boyd RT,
Jacob MH,
Mc Earchern AE,
Caron S,
Berg DK
(1991)
Nicotinic acetylcholine receptor mRNA in dorsal root ganglion neurons.
J Neurobiol
22:1-14[Web of Science][Medline].
-
Bretag A
(1969)
Synthetic interstitial fluid for isolated mammalian tissue.
Life Sci
8:319-329[Web of Science][Medline].
-
Buchli R,
Ndoye A,
Rodriguez JG,
Zia S,
Webber RJ,
Grando SA
(1999)
Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors.
J Cell Biochem
74:264-277[Web of Science][Medline].
-
Caulfield MP
(1993)
Muscarinic receptors: characterization, coupling and function.
Pharmacol Ther
58:319-379[Web of Science][Medline].
-
Caulfield MP,
Birdsall NGM
(1998)
International union pharmacology. XVII. Classification of muscarinic acetylcholine receptors.
Pharmacol Rev
50:279-290[Abstract/Free Full Text].
-
Ellis JL,
Harman D,
Gonzales J,
Spera ML,
Liu R,
Shen TY,
Wypij M,
Zuo F
(1999)
Development of muscarinic analgesics derived from epibatidine: role of the M4 receptor subtype.
J Pharmacol Exp Ther
288:1143-1150[Abstract/Free Full Text].
-
Flores CM,
DeCamp RM,
Kilo S,
Scott WR,
Hargreaves KM
(1996)
Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of
3 4, a novel subtype in the mammalian nervous system.
J Neurosci
16:7892-7901[Abstract/Free Full Text]. -
Forssmann WG,
Itoh S,
Weihe E,
Aoki A,
Dym DM,
Fawcett DW
(1977)
An improved perfusion fixation method for the testis.
Anat Rec
188:307-318[Medline].
-
Forster C,
Handwerker HO
(1990)
Automatic classification and analysis of microneurographic spike data using a PC/AT.
J Neurosci Methods
31:109-118[Web of Science][Medline].
-
Gomeza J,
Shannon H,
Kostenis E,
Felder C,
Zhang L,
Brodkin J,
Grinberg A,
Sheng H,
Wess J
(1999)
Pronounced pharmacological deficits in M2 muscarinic acetylcholine receptor knockout mice.
Proc Natl Acad Sci USA
96:1692-1697[Abstract/Free Full Text].
-
Grando SA,
Kist DA,
Qi M,
Dahl MV
(1993)
Human keratinocytes synthesize, secrete and degrade acetylcholine.
J Invest Dermatol
101:32-36[Web of Science][Medline].
-
Haberberger RV,
Bodenbenner M
(2000)
Immunohistochemical localization of muscarinic receptors (M2) in the rat skin.
Cell Tissue Res
300:389-396[Web of Science][Medline].
-
Haberberger R,
Henrich M,
Couraud JY,
Kummer W
(1999)
Muscarinic M2-receptors in rat thoracic dorsal root ganglia.
Neurosci Lett
266:177-180[Web of Science][Medline].
-
Harkins AB,
Fox AP
(1998)
Activation of nicotinic acetylcholine receptors augments calcium channel-mediated exocytosis in rat pheochromocytoma (PC12) cells.
J Gen Physiol
111:257-269[Abstract/Free Full Text].
-
Iggo A
(1958)
The electrophysiological identification of single nerve fibers, with particular reference to the slowest-conducting vagal afferent fibers in the cat.
J Physiol (Lond)
142:110-126.
-
Keele CA,
Armstrong D
(1964)
In: Substances producing pain and itch. London: Edward Arnold.
-
Kress M,
Guenther S
(1999)
Role of [Ca 2+]i in the ATP-induced heat sensitization process of rat nociceptive neurons.
J Neurophysiol
81:2612-2619[Abstract/Free Full Text].
-
Kress M,
Rödl J,
Reeh PW
(1996)
Stable analogues of cyclic AMP but not cyclic GMP sensitize unmyelinated primary afferents in rat skin to heat stimulation but not to inflammatory mediatora, in vitro.
Neuroscience
74:609-617[Web of Science][Medline].
-
Lindstrom J,
Anand R,
Gerzanich V,
Peng X,
Wang F,
Wells G
(1996)
Structure and function of neuronal nicotinic acetylcholine receptors.
Prog Brain Res
109:125-137[Web of Science][Medline].
-
Liu L,
Chang G-Q,
Jiao YQ,
Simon SA
(1998)
Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia.
Brain Res
809:238-245[Web of Science][Medline].
-
Mei L,
Roeske WR,
Yamamura HI
(1989)
Molecular pharmacology of muscarinic receptor heterogeneity.
Life Sci
45:1831-1851[Medline].
-
Naguib M,
Yaksh TL
(1997)
Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord.
Anesth Analg
85:847-853[Abstract].
-
Page AJ,
Blackshaw LA
(1999)
GABAB receptors inhibit mechanosensitivity of primary afferent endings.
J Neurosci
19:8597-8602[Abstract/Free Full Text].
-
Pan ZZ,
Williams JT
(1994)
Muscarine hyperpolarizes a subpopulation of neurons by activating an M2 muscarinic receptor in rat nucleous raphe magnus in vitro.
J Neurosci
14:1332-1338[Abstract].
-
Pesin SR,
Candia O
(1982)
Acetylcholine concentration and its role in ionic transport by the corneal epithelium.
Invest Ophthalmol Vis Sci
22:651-659[Abstract/Free Full Text].
-
Rao TS,
Correa LD,
Reih RT,
Lloyd GK
(1996)
Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (nAChR) ligands in the rat tail-flick assay.
Neuropharmacology
35:393-405[Web of Science][Medline].
-
Reeh PW
(1986)
Sensory receptors in mammalian skin in an in vitro preparation.
Neurosci Lett
66:141-146[Web of Science][Medline].
-
Reeh PW
(1988)
Sensory receptors in mammalian skin-nerve in vitro preparation.
In: Progress in brain research. Transduction and cellular mechanisms in sensory receptors (Hamann W,
Iggo A,
eds), pp 271-276. Elsevier: Amsterdam.
-
Roberts RG,
Stevenson JE,
Westerman RA,
Pennefather J
(1995)
Nicotinic acetylcholine receptors on capsaicin-sensitive nerves.
NeuroReport
6:1578-1582[Web of Science][Medline].
-
Rukwied R,
Heyer G
(1999)
Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients.
Exp Dermatol
8:39-45[Web of Science][Medline].
-
Steen KH,
Reeh PW
(1993)
Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro.
J Neurophysiol
70:397-405[Abstract/Free Full Text].
-
Sucher NJ,
Cheng TPO,
Lipton SA
(1990)
Neural nicotinic acetylcholine responses in sensory neurons from postnatal rat.
Brain Res
533:248-254[Web of Science][Medline].
-
Tanellian DL
(1991)
Cholinercic activation of a population of corneal afferent nerves.
Exp Brain Res
86:414-420[Web of Science][Medline].
-
Tata AM,
Plateroti M,
Cibati M,
Biagioni S,
Augusti-Tocco G
(1994)
Cholinergic markers are expressed in developing and mature neurons of chick dorsal root ganglia.
J Neurosci Res
37:247-255[Web of Science][Medline].
-
Tata AM,
Vilaró MT,
Agrati C,
Biagioni S,
Mengod G,
Augusti-Tocco G
(1999)
Expression of muscarinic M2 receptor mRNA in dorsal root ganglia of neonatal rat.
Brain Res
824:63-70[Web of Science][Medline].
-
Tata AM,
Tripiciano A,
Filippini A,
Biagioni S,
Augusti-Tocco G
(2000)
Muscarinic receptors modulate intracellular calcium level in chock sensory neurons.
Brain Res Mol Brain Res
82:1-10[Medline].
-
Traynor JR
(1998)
Epibatidine and pain.
Br J Anaesth
81:69-76[Free Full Text].
-
Wanke E,
Bianchi L,
Mantegazza M,
Guatteo E,
Mancinelli E,
Ferroni A
(1994)
Muscarinic regulation of Ca2+ currents in rat sensory neurons: channel and receptors types, dose-response relationships and cross-talk pathways.
Eur J Neurosci
6:381-391[Web of Science][Medline].
-
Wessler I,
Reinheimer T,
Klapproth H,
Schneider FJ,
Racke K,
Hammer R
(1997)
Mammalian glial cells in culture synthesize acetylcholine.
Naunyn Schmiedeberg's Arch Pharmacol
356:694-697[Web of Science][Medline].
-
Wessler I,
Kirkpatrick CJ,
Racke K
(1998)
Non- neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans.
Pharmacol Ther
77:59-79[Web of Science][Medline].
-
Wessler I,
Kirkpatrick CJ,
Racke K
(1999)
The cholinergic "pitfall": acetylcholine, a universal cell molecule in biological systems, including humans.
Clin Exp Pharmacol Physiol
26:198-205[Web of Science][Medline].
-
Yang LC,
Chen LM,
Wang CJ,
Buerkle H
(1998)
Postoperative analgesia by intra-articular neostigmine in patients undergoing knee arthroscopy.
Anesthesiology
88:334-339[Web of Science][Medline].
-
Zamboni L,
de Martino C
(1967)
Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy.
J Cell Biol
35:148.
-
Zhong H,
Nurse CA
(1997)
Nicotinic acetylcholine sensitivity of rat petrosal sensory neurons in dissociated cell culture.
Brain Res
766:153-161[Web of Science][Medline].
-
Zoli M,
Le Noveré N,
Hill JA,
Changeux JP
(1995)
Developmental regulation of nicotinic ACh receptor subunit mRNA in the rat central and peripheral nervous system.
J Neurosci
15:1912-1939[Abstract].
Copyright © 2001 Society for Neuroscience 0270-6474/01/2193295-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
N. Tokushige, R. Markham, P. Russell, and I. S. Fraser
Nerve fibres in peritoneal endometriosis
Hum. Reprod.,
November 1, 2006;
21(11):
3001 - 3007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fucile, A. Sucapane, and F. Eusebi
Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones
J. Physiol.,
May 15, 2005;
565(1):
219 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Schlereth, N. Brosda, and F. Birklein
Spreading of sudomotor axon reflexes in human skin
Neurology,
April 26, 2005;
64(8):
1417 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Rau, R. D. Johnson, and B. Y. Cooper
Nicotinic AChR in Subclassified Capsaicin-Sensitive and -Insensitive Nociceptors of the Rat DRG
J Neurophysiol,
March 1, 2005;
93(3):
1358 - 1371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Goldstein, S. Pechnik, J. Moak, and B. Eldadah
Painful sweating
Neurology,
October 26, 2004;
63(8):
1471 - 1475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O. Warner, M. J. Joyner, and N. Charkoudian
Nicotine increases initial blood flow responses to local heating of human non-glabrous skin
J. Physiol.,
September 15, 2004;
559(3):
975 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Lang, R. Burgstahler, W. Sippel, D. Irnich, B. Schlotter-Weigel, and P. Grafe
Characterization of Neuronal Nicotinic Acetylcholine Receptors in the Membrane of Unmyelinated Human C-Fiber Axons by In Vitro Studies
J Neurophysiol,
November 1, 2003;
90(5):
3295 - 3303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Stander, M. Steinhoff, M. Schmelz, E. Weisshaar, D. Metze, and T. Luger
Neurophysiology of Pruritus: Cutaneous Elicitation of Itch
Arch Dermatol,
November 1, 2003;
139(11):
1463 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Distler, P. K. Rathee, K. S. Lips, O. Obreja, W. Neuhuber, and M. Kress
Fast Ca2+-Induced Potentiation of Heat-Activated Ionic Currents Requires cAMP/PKA Signaling and Functional AKAP Anchoring
J Neurophysiol,
May 1, 2003;
89(5):
2499 - 2505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bernardini, C. Roza, S. K. Sauer, J. Gomeza, J. Wess, and P. W. Reeh
Muscarinic M2 Receptors on Peripheral Nerve Endings: A Molecular Target of Antinociception
J. Neurosci.,
May 31, 2002;
(2002)
20026476.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|